Quest Diagnostics Incorporated (DGX)

Quest Diagnostics Incorporated is a healthcare company focused on diagnostic testing and related services in the United States. Through its laboratory network and patient service centers, the company provides clinical testing across routine, advanced, and specialized areas, including anatomic pathology, cardiometabolic and endocrine testing, cancer diagnostics, infectious disease, neurology, women’s health, drug monitoring, and toxicology. Its services are delivered under the Quest Diagnostics name and through brands such as AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum. Quest Diagnostics also serves a broad base of customers that includes physicians, hospitals, patients, health plans, employers, government agencies, retailers, pharmaceutical companies, insurers, and accountable care organizations. In addition, it offers healthcare IT, population health, risk assessment, employer screening, and other diagnostic and data-driven services. The company was founded in 1967 and is headquartered in Secaucus, New Jersey.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.